BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 31923133)

  • 1. Comparative Clinical Effectiveness and Safety of Bone Morphogenetic Protein Versus Autologous Iliac Crest Bone Graft in Lumbar Fusion: A Meta-analysis and Systematic Review.
    Liu S; Wang Y; Liang Z; Zhou M; Chen C
    Spine (Phila Pa 1976); 2020 Jun; 45(12):E729-E741. PubMed ID: 31923133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human bone morphogenetic protein-2 versus autogenous iliac crest bone graft for lumbar fusion: a meta-analysis of ten randomized controlled trials.
    Chen Z; Ba G; Shen T; Fu Q
    Arch Orthop Trauma Surg; 2012 Dec; 132(12):1725-40. PubMed ID: 22941273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the use of rhBMP-7 versus iliac crest autograft in single-level lumbar fusion: a meta-analysis of randomized controlled trials.
    Ye F; Zeng Z; Wang J; Liu H; Wang H; Zheng Z
    J Bone Miner Metab; 2018 Jan; 36(1):119-127. PubMed ID: 28342094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative and long-term clinical outcomes for bone morphogenetic protein versus iliac crest bone graft for lumbar fusion in degenerative disk disease: systematic review with meta-analysis.
    Noshchenko A; Hoffecker L; Lindley EM; Burger EL; Cain CM; Patel VV
    J Spinal Disord Tech; 2014 May; 27(3):117-35. PubMed ID: 24945290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RhBMP-2 versus iliac crest bone graft for lumbar spine fusion: a randomized, controlled trial in patients over sixty years of age.
    Glassman SD; Carreon LY; Djurasovic M; Campbell MJ; Puno RM; Johnson JR; Dimar JR
    Spine (Phila Pa 1976); 2008 Dec; 33(26):2843-9. PubMed ID: 19092613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of recombinant human bone morphogenetic protein-2 with local bone graft instead of iliac crest bone graft in posterolateral lumbar spine arthrodesis.
    Park DK; Kim SS; Thakur N; Boden SD
    Spine (Phila Pa 1976); 2013 May; 38(12):E738-47. PubMed ID: 23474598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
    Crawford CH; Carreon LY; McGinnis MD; Campbell MJ; Glassman SD
    Spine (Phila Pa 1976); 2009 Jun; 34(13):1390-4. PubMed ID: 19440166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is lumbar facet fusion biomechanically equivalent to lumbar posterolateral onlay fusion?
    Toth JM; Foley KT; Wang M; Seim HB; Simon Turner A
    J Neurosurg Spine; 2017 May; 26(5):586-593. PubMed ID: 28156207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
    Haid RW; Branch CL; Alexander JT; Burkus JK
    Spine J; 2004; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis.
    Dimar JR; Glassman SD; Burkus JK; Pryor PW; Hardacker JW; Carreon LY
    J Bone Joint Surg Am; 2009 Jun; 91(6):1377-86. PubMed ID: 19487515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone union rate with recombinant human bone morphogenic protein-2 versus autologous iliac bone in PEEK cages for anterior lumbar interbody fusion.
    Flouzat-Lachaniette CH; Ghazanfari A; Bouthors C; Poignard A; Hernigou P; Allain J
    Int Orthop; 2014 Sep; 38(9):2001-7. PubMed ID: 24627122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
    Dimar JR; Glassman SD; Burkus KJ; Carreon LY
    Spine (Phila Pa 1976); 2006 Oct; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. rhBMP-2 for posterolateral instrumented lumbar fusion: a multicenter prospective randomized controlled trial.
    Hurlbert RJ; Alexander D; Bailey S; Mahood J; Abraham E; McBroom R; Jodoin A; Fisher C
    Spine (Phila Pa 1976); 2013 Dec; 38(25):2139-48. PubMed ID: 24296479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of rhBMP-2 for posterolateral lumbar fusion in smokers.
    Glassman SD; Dimar JR; Burkus K; Hardacker JW; Pryor PW; Boden SD; Carreon LY
    Spine (Phila Pa 1976); 2007 Jul; 32(15):1693-8. PubMed ID: 17621221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of autologous iliac crest bone graft and bone morphogenetic proteins for posterolateral fusion of lumbar spine: a meta-analysis of the results.
    Papakostidis C; Kontakis G; Bhandari M; Giannoudis PV
    Spine (Phila Pa 1976); 2008 Sep; 33(19):E680-92. PubMed ID: 18758349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The perioperative cost of Infuse bone graft in posterolateral lumbar spine fusion.
    Glassman SD; Carreon LY; Campbell MJ; Johnson JR; Puno RM; Djurasovic M; Dimar JR
    Spine J; 2008; 8(3):443-8. PubMed ID: 17526436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long adult spinal deformity fusion to the sacrum using rhBMP-2 versus autogenous iliac crest bone graft.
    Maeda T; Buchowski JM; Kim YJ; Mishiro T; Bridwell KH
    Spine (Phila Pa 1976); 2009 Sep; 34(20):2205-12. PubMed ID: 19752707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot safety and efficacy study of OP-1 putty (rhBMP-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions.
    Vaccaro AR; Patel T; Fischgrund J; Anderson DG; Truumees E; Herkowitz H; Phillips F; Hilibrand A; Albert TJ
    Eur Spine J; 2003 Oct; 12(5):495-500. PubMed ID: 12908103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoinductive bone graft substitutes for lumbar fusion: a systematic review.
    Agarwal R; Williams K; Umscheid CA; Welch WC
    J Neurosurg Spine; 2009 Dec; 11(6):729-40. PubMed ID: 19951027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies.
    Boden SD; Kang J; Sandhu H; Heller JG
    Spine (Phila Pa 1976); 2002 Dec; 27(23):2662-73. PubMed ID: 12461392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.